Early and accurate detection of eye diseases, including diabetic retinopathy, macular edema, age-related macular degeneration (AMD), and glaucoma, remains a major challenge in ophthalmology due to the inherent limitations of single-modality imaging. Fundus photography captures surface-level vascular and optic disc information but lacks depth, while optical coherence tomography (OCT) provides high-resolution cross-sectional details of retinal layers but misses surface-level cues. To overcome these shortcomings, we propose an optimized hierarchical dual-modality feature pyramid network (OHDM-FPN) that integrates fundus and OCT images for robust multimodal eye disease detection. The framework employs EfficientNetV2-Small as the encoder for fundus images and GhostNet with dilated residual blocks for OCT feature extraction. Each modality is processed through a feature pyramid network (FPN) with atrous spatial pyramid pooling (ASPP) to improve multi-scale representations. A cross-modality multi-scale fusion block (CM-MSFB), enriched with channel-spatial attention (CBAM) and deformable convolutions, aligns and fuses modality-specific features. Finally, a lightweight classification head predicts disease categories, while hyperparameter tuning via the Salmon Salar optimization (SSO) algorithm addresses class imbalance and improves generalization. Experiments were executed on a combined fundus–OCT benchmark dataset (EyePACS + Duke OCT). The proposed OHDM-FPN achieved 98.2% accuracy, 97.9% sensitivity, 98.7% specificity, 0.993 AUC, and 98.1% F1-score, outperforming state-of-the-art single-modality models by an average margin of 6.3% in accuracy and 5.8% in AUC. Moreover, the fusion mechanism improved early-stage disease detection rates by 9.1% compared to OCT-only baselines. Attention heat maps confirmed that OHDM-FPN focused on clinically relevant retinal regions, improving interpretability for ophthalmologists. These results demonstrate that OHDM-FPN provides a powerful, optimized, and interpretable multimodal solution for eye disease detection, offering significant improvements in diagnostic performance and early intervention potential.
No takes yet. Share an insight, caveat, or question.
Kiruthiga et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: